Results 11 to 20 of about 9,200 (223)

Calcitonin gene-related peptide-targeting drugs and Raynaud’s phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database

open access: yesThe Journal of Headache and Pain, 2022
Background Migraine is responsible for significant disability and societal burden. Recently, drugs targeting the calcitonin gene-related peptide (CGRP) pathway raised new hopes. CGRP, a potent vasodilator, plays a key role in the pathogenesis of migraine
Alexandre O. Gérard   +6 more
doaj   +1 more source

Raynaud's phenomenon [PDF]

open access: yesClinical Medicine, 2020
Raynaud's phenomenon (RP) is a common vasospastic condition which affects ~5% of the general population. The majority of individuals have primary RP; however, Raynaud's can also occur secondary to a broad range of underlying medical conditions and drug therapies.
Haque, Ashraful   +1 more
openaire   +3 more sources

Incidence, remission, and persistence of Raynaud’s phenomenon in the general population of northern Sweden: a prospective study

open access: yesBMC Rheumatology, 2022
Background Raynaud’s phenomenon is common condition, but little is known about the natural course. The primary aim of this study was to determine the incidence, remission, and persistence proportions of Raynaud’s phenomenon in the general population of ...
Albin Stjernbrandt   +5 more
doaj   +1 more source

Aptamer proteomics of serum exosomes from patients with Primary Raynaud's and patients with Raynaud's at risk of evolving into Systemic Sclerosis.

open access: yesPLoS ONE, 2022
BackgroundA major unmet need for Systemic Sclerosis (SSc) clinical management is the lack of biomarkers for the early diagnosis of patients with Raynaud's Phenomenon at high risk of evolving into SSc.ObjectiveTo identify proteins contained within serum ...
Sonsoles Piera-Velazquez   +4 more
doaj   +1 more source

Impact of global warming on Raynaud’s phenomenon: a modelling study [version 1; peer review: 2 approved]

open access: yesF1000Research, 2020
Background: Raynaud’s phenomenon is induced by excessive vasoconstriction of the peripheral microcirculation in response to environmental factors, essentially cold, but also stress or emotions. The objective of the present study is to evaluate the impact
Charles Khouri   +2 more
doaj   +1 more source

Raynaud’s Phenomenon

open access: yesNew England Journal of Medicine, 1996
Raynaud's phenomenon is a common clinical problem occurring in 3% to 5% of the general population. The first symptom of scleroderma is often Raynaud's phenomenon, which is associated with a diffuse small vessel vasculopathy and ischemia and reperfusion injury to skin and other organs targeted in this disease.
F M, Wigley, N A, Flavahan
openaire   +3 more sources

Postocclusive reactive hyperemia in hand-arm vibration syndrome

open access: yesInternational Journal of Occupational Medicine and Environmental Health, 2016
Objectives: To assess laser Doppler-recorded postocclusive reactive hyperemic responses in vibration-induced Raynaud’s phenomenon and compare it with primary and secondary to sclerodermy Raynaud’s phenomenon.
Zlatka Stoyneva
doaj   +1 more source

Raynaud’s phenomenon as an interdisciplinary problem

open access: yesPrzegląd Dermatologiczny, 2017
Raynaud’s phenomenon is one of the most common disorders of the blood vessels, which usually affects fingers and toes. Raynaud’s disease, also called primary Raynaud’s phenomenon, is diagnosed when the cause is unknown, whereas Raynaud’s syndrome or ...
Karolina Górska   +5 more
doaj   +1 more source

Characteristic of microcirculatory changes in patients with primary Raynod's phenomenon by videocapillaroscopy

open access: yesНаучно-практическая ревматология, 2003
Objective. To study prevalence and structure of videocapillaroscopic findings in primary Raynaud's phenomenon (PRP) and their relation to clinical picture. Methods. 20 pts with PRP and 15 controls were examined by videocapillaroscopy. Results.
T A Nevskaya, N G Guseva
doaj   +1 more source

Home - About - Disclaimer - Privacy